EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Post‐translational regulation of human D‐3‐phosphoglycerate dehydrogenase in Alzheimer's disease

Elena Zerbini, Daniele Riva, Elisa Maffioli, Gabriella Tedeschi, Silvia Sacchi iD, Loredano Pollegioni iD

Protein Science · 2026

DOI: 10.1002/pro.70505 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, 2026. Verfasst von Elena Zerbini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Phosphoglycerate Dehydrogenase, Protein Processing, Post-Translational. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence suggests that sex‐specific differences in L‐serine (L‐Ser) metabolism play a key role in Alzheimer's disease (AD). While disruptions in amino acid balance are well known, recent findings point to a dimorphic regulation of the serine biosynthetic pathway. To explore this, we examined post‐translational modifications (PTMs) of D‐3‐phosphoglycerate dehydrogenase (PHGDH)—the rate‐limiting enzyme for de novo L‐Ser synthesis—as a potentialmechanism underlying this difference. PHGDH was immunoprecipitated from hippocampal tissue of healthy and AD‐affected males and females and analyzed by mass spectrometry. Five phosphorylation sites (S55, T60, T78, S383, and S473) were shared across all groups, but a unique deacetylation at K289 appeared exclusively in AD males. Functional assays using recombinant PHGDH variants revealed that changes at solvent‐exposed sites (K289, S383, and S473) reduced solubility, while phosphomimetic substitutions at S55 and T78 within the catalytic cleft strongly impaired activity. Notably, mimicking acetylation at K289 improved protein stability. Overall, these PTMs act both as subtle modulators and as on/off switches, fine‐tuning PHGDH function and potentially contributing to sex‐dependent metabolic vulnerability in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseasePhosphoglycerate DehydrogenaseProtein Processing, Post-TranslationalHumansMaleFemalePhosphorylationSerineAcetylationHippocampus

Stichwörter der Autor:innen

PHGDHacetylationenzyme regulationphosphorylationserine

Substanzen

Phosphoglycerate DehydrogenaseSerine

Autor:innen und Institutionen

  • Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.
  • Department of Veterinary Medicine and Animal Science, University of Milano, Lodi, Italy.

ORCID-Profile: Silvia Sacchi, Loredano Pollegioni

Förderung

  • Ministero dell'Università e della Ricerca

Zitieren

APA

Zerbini, E., Riva, D., Maffioli, E., Tedeschi, G., Sacchi, S., & Pollegioni, L. (2026). Post‐translational regulation of human D‐3‐phosphoglycerate dehydrogenase in Alzheimer's disease. Protein Science. https://doi.org/10.1002/pro.70505

Vancouver

Zerbini E, Riva D, Maffioli E, Tedeschi G, Sacchi S, Pollegioni L. Post‐translational regulation of human D‐3‐phosphoglycerate dehydrogenase in Alzheimer's disease. Protein Science. 2026. doi:10.1002/pro.70505

BibTeX
@article{Zerbini2026,
  author = {Zerbini, Elena and Riva, Daniele and Maffioli, Elisa and Tedeschi, Gabriella and Sacchi, Silvia and Pollegioni, Loredano},
  title = {Post‐translational regulation of human D‐3‐phosphoglycerate dehydrogenase in Alzheimer's disease},
  journal = {Protein Science},
  year = {2026},
  doi = {10.1002/pro.70505}
}
Kostenlos starten →